125 related articles for article (PubMed ID: 2161152)
1. Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies.
Okuno T; Sao H; Asada H; Shiraki K; Takahashi M; Yamanishi K
Virology; 1990 Jun; 176(2):625-8. PubMed ID: 2161152
[TBL] [Abstract][Full Text] [Related]
2. Analysis of human herpesvirus 6 glycoproteins recognized by monoclonal antibody OHV1.
Okuno T; Shao H; Asada H; Shiraki K; Takahashi M; Yamanishi K
J Gen Virol; 1992 Feb; 73 ( Pt 2)():443-7. PubMed ID: 1311366
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens.
Okuno T; Yamanishi K; Shiraki K; Takahashi M
Virology; 1983 Sep; 129(2):357-68. PubMed ID: 6312679
[TBL] [Abstract][Full Text] [Related]
4. Electrophoretic analysis of human herpesvirus 6 polypeptides immunoprecipitated from infected cells with human sera.
Balachandran N; Tirawatnapong S; Pfeiffer B; Ablashi DV; Salahuddin SZ
J Infect Dis; 1991 Jan; 163(1):29-34. PubMed ID: 1845808
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
[TBL] [Abstract][Full Text] [Related]
6. Identification of proteins specific for human herpesvirus 6-infected human T cells.
Balachandran N; Amelse RE; Zhou WW; Chang CK
J Virol; 1989 Jun; 63(6):2835-40. PubMed ID: 2786090
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to gp100 inhibit penetration of human herpesvirus 6 and polykaryocyte formation in susceptible cells.
Foà-Tomasi L; Boscaro A; di Gaeta S; Campadelli-Fiume G
J Virol; 1991 Aug; 65(8):4124-9. PubMed ID: 1649319
[TBL] [Abstract][Full Text] [Related]
8. Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6.
Foà-Tomasi L; Avitabile E; Ke L; Campadelli-Fiume G
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2719-27. PubMed ID: 7931158
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing monoclonal antibodies directed to infectious bovine rhinotracheitis virus.
Chang LW; Zee YC; Pritchett RF; Ardans AA
Arch Virol; 1986; 88(3-4):203-15. PubMed ID: 3010905
[TBL] [Abstract][Full Text] [Related]
10. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
[TBL] [Abstract][Full Text] [Related]
11. Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies.
Forghani B; Dupuis KW; Schmidt NJ
J Virol; 1984 Oct; 52(1):55-62. PubMed ID: 6090710
[TBL] [Abstract][Full Text] [Related]
12. Characterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cells.
Patick AK; Hinze HC
J Virol; 1987 Nov; 61(11):3580-8. PubMed ID: 3312635
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human herpesvirus-6(U1102) and (GS) gp112 and identification of the Z29-specified homolog.
Foà-Tomasi L; Guerrini S; Huang T; Campadelli-Fiume G
Virology; 1992 Nov; 191(1):511-6. PubMed ID: 1329335
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes.
Kari B; Lussenhop N; Goertz R; Wabuke-Bunoti M; Radeke R; Gehrz R
J Virol; 1986 Nov; 60(2):345-52. PubMed ID: 3021969
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2.
Balachandran N; Hutt-Fletcher LM
J Virol; 1985 Jun; 54(3):825-32. PubMed ID: 2987534
[TBL] [Abstract][Full Text] [Related]
16. Feline herpesvirus type 1 glycoproteins eliciting virus neutralizing and hemagglutination-inhibiting antibodies.
Horimoto T; Limcumpao JA; Tohya Y; Takahashi E; Mikami T
Arch Virol; 1990; 111(1-2):127-32. PubMed ID: 2327898
[TBL] [Abstract][Full Text] [Related]
17. Antigenic analysis of human herpesvirus 7 (HHV-7) and HHV-6 using immune sera and monoclonal antibodies against HHV-7.
Nakagawa N; Mukai T; Sakamoto J; Hata A; Okuno T; Takeda K; Yamanishi K
J Gen Virol; 1997 May; 78 ( Pt 5)():1131-7. PubMed ID: 9152434
[TBL] [Abstract][Full Text] [Related]
18. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
Sugano T; Tomiyama T; Matsumoto Y; Sasaki S; Kimura T; Forghani B; Masuho Y
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
[TBL] [Abstract][Full Text] [Related]
19. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).
Montalvo EA; Grose C
Virology; 1986 Mar; 149(2):230-41. PubMed ID: 2418586
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 8 glycoprotein K8.1: expression, post-translational modification and localization analyzed by monoclonal antibody.
Wu L; Renne R; Ganem D; Forghani B
J Clin Virol; 2000 Aug; 17(2):127-36. PubMed ID: 10942093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
